FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980746331> ?p ?o ?g. }

• W2980746331 abstract "Aims Macrovascular complications of diabetes are seen prematurely in adulthood, but screening for risk factors in childhood (lipids, blood pressure and obesity) may prevent future adverse outcomes. The National Paediatric Diabetes Audit requires their measurement but only blood pressure and BMI contribute to key care processes. The current NICE (2016) guidance on childhood type 1 diabetes does not require lipid screening and has no specific advice on dyslipidaemia. Method We analysed lipid data obtained for those 12–19 years old children and young people (CYP) under care of our diabetes service over a 4.5 years period from January 2014 to July 2018. 348 sets of results representing 160 patients were included. Results Using published ‘normal’ total cholesterol values of up to 4 mmol/L, we found 66% of CYP exceeded this value, 23.1% had cholesterol levels above 5 mmol/L. 9 CYP (5%) had values above 6 mmol/L, raising the possibility of additional familial hypercholesterolaemia (FH). For those 106 CYP with a Cholesterol>4 mmol/L (106 patients) there was no correlation between cholesterol and HbA1c or BMI. For those CYP with a Cholesterol >6 mmol/L and high Triglycerides (6 patients) dyslipidaemia this appeared related to poorly controlled diabetes (High HbA1C) or weight (High BMI for Age), the latter potentially related to insulin resistance. There were 3 CYP with serum Cholesterol >6 mmol/L, normal Triglycerides, high LDL., one of whom probably has Familial Hypercholesterolaemia, and had very high HDL cholesterol levels possibly linked to Familial Hyperalphalipoproteinaemia. Conclusions Analysis of the data determined a significant number of CYP with diabetes have established lipid abnormalities, which are not being actively treated. There are currently no clear guidelines for managing paediatric dyslipidaemia. Pharmacological management in childhood is controversial, and recommended management is lifestyle modification by diet and exercise although data on the benefits in CYP is lacking. The impact of statins on surrogate measures of macrovascular complications in CYP with Type 1 diabetes is contentious. The potential of concomitant FH requiring consideration of statin therapy post puberty would be in line with national guidance and requires a detailed family history." @default.
• W2980746331 created "2019-10-25" @default.
• W2980746331 creator A5013549706 @default.
• W2980746331 creator A5017260823 @default.
• W2980746331 creator A5066403738 @default.
• W2980746331 creator A5088483234 @default.
• W2980746331 date "2019-05-01" @default.
• W2980746331 modified "2023-09-26" @default.
• W2980746331 title "G572(P) What do we do with lipid levels measured as part of the national paediatric diabetes audit?" @default.
• W2980746331 doi "https://doi.org/10.1136/archdischild-2019-rcpch.553" @default.
• W2980746331 hasPublicationYear "2019" @default.
• W2980746331 type Work @default.
• W2980746331 sameAs 2980746331 @default.
• W2980746331 citedByCount "0" @default.
• W2980746331 crossrefType "proceedings-article" @default.
• W2980746331 hasAuthorship W2980746331A5013549706 @default.
• W2980746331 hasAuthorship W2980746331A5017260823 @default.
• W2980746331 hasAuthorship W2980746331A5066403738 @default.
• W2980746331 hasAuthorship W2980746331A5088483234 @default.
• W2980746331 hasConcept C126322002 @default.
• W2980746331 hasConcept C134018914 @default.
• W2980746331 hasConcept C2777391703 @default.
• W2980746331 hasConcept C2778163477 @default.
• W2980746331 hasConcept C2779422640 @default.
• W2980746331 hasConcept C2780586474 @default.
• W2980746331 hasConcept C511355011 @default.
• W2980746331 hasConcept C555293320 @default.
• W2980746331 hasConcept C71924100 @default.
• W2980746331 hasConcept C84393581 @default.
• W2980746331 hasConceptScore W2980746331C126322002 @default.
• W2980746331 hasConceptScore W2980746331C134018914 @default.
• W2980746331 hasConceptScore W2980746331C2777391703 @default.
• W2980746331 hasConceptScore W2980746331C2778163477 @default.
• W2980746331 hasConceptScore W2980746331C2779422640 @default.
• W2980746331 hasConceptScore W2980746331C2780586474 @default.
• W2980746331 hasConceptScore W2980746331C511355011 @default.
• W2980746331 hasConceptScore W2980746331C555293320 @default.
• W2980746331 hasConceptScore W2980746331C71924100 @default.
• W2980746331 hasConceptScore W2980746331C84393581 @default.
• W2980746331 hasLocation W29807463311 @default.
• W2980746331 hasOpenAccess W2980746331 @default.
• W2980746331 hasPrimaryLocation W29807463311 @default.
• W2980746331 hasRelatedWork W126148468 @default.
• W2980746331 hasRelatedWork W1851040735 @default.
• W2980746331 hasRelatedWork W1997714682 @default.
• W2980746331 hasRelatedWork W2001957724 @default.
• W2980746331 hasRelatedWork W2051624906 @default.
• W2980746331 hasRelatedWork W2055938623 @default.
• W2980746331 hasRelatedWork W2103403372 @default.
• W2980746331 hasRelatedWork W2117405666 @default.
• W2980746331 hasRelatedWork W2127045416 @default.
• W2980746331 hasRelatedWork W2141547234 @default.
• W2980746331 hasRelatedWork W2257573251 @default.
• W2980746331 hasRelatedWork W2297008923 @default.
• W2980746331 hasRelatedWork W2356309063 @default.
• W2980746331 hasRelatedWork W2397623816 @default.
• W2980746331 hasRelatedWork W2436560990 @default.
• W2980746331 hasRelatedWork W2473255808 @default.
• W2980746331 hasRelatedWork W291396684 @default.
• W2980746331 hasRelatedWork W3014382810 @default.
• W2980746331 hasRelatedWork W3034675111 @default.
• W2980746331 hasRelatedWork W3188459602 @default.
• W2980746331 isParatext "false" @default.
• W2980746331 isRetracted "false" @default.
• W2980746331 magId "2980746331" @default.
• W2980746331 workType "article" @default.